ENZA-p trial The Lancet Oncology
authors.elsevier.com/a/1iw3e5EIIgPd…
Enzalutamide + adaptive-dosed (2 or 4) 177 Lu-PSMA617 vs enza alone in mCRPC.
Biomarker guided combination therapy works!
Better response depth/duration with no added tox. ANZUP NHMRC CTC Movember Australia St Vincent's Sydney

SPECT images obtained +24h after administration of Lu177 therapy can provide valuable information and can impact patient management. #theranostics
JNM Thomas Hope SurekhaYadav MD
jnm.snmjournals.org/content/65/3/4…

Is EXCITED about:
- Upcoming talks at #SNMMI #MidWinterMeeting by some of the distinguished figures in theranostics Thomas Hope Lisa Bodei, MD, PhD Rob Flavell
- My talk on Volumetric Analysis in SSTR Imaging
- Presenting our results on Impact of Post treatment Imaging in PRRT

Kate 💙 #LetsTalkAboutNETs Neuroendocrine Cancer UK #NotJustNECancer The ACTION-1 trial from RayzeBio doesn't include bronchial NETs. But please get the word out about our Alliance trial that compares 177Lu-DOTATATE to everolimus in patients with bronchial NETs (NCT04665739). Currently enrolling!

Evaluation of the primary tumor with PSMA PET: time impact of the #PRIMARY trial. Presented by Louise Emmett. Written coverage of the #2024PSMAConference by Zach Klaassen on UroToday > bit.ly/3O8G4Kg PSMA conference - UCSF/UCLA/PCF/Urotoday UCSF Helen Diller Family Comprehensive Cancer Ctr UCLA Jonsson Comprehensive Cancer Center Prostate Cancer Foundation

Maybe 117Lu-PSMA SPECT/CT total tumor burden inter-cycle could predict progression ?

Is this possible and easy to do in real world ?

Louise Emmett Jeremie Calais PSMA conference - UCSF/UCLA/PCF/Urotoday MIM Software ProsTIC

How should we follow up 177Lu-PSMA cycles with imaging?

☑️ Bone scan: low specificity, why continue being guidelines option??
☑️ PPP criteria: focus in new lesions
☑️ RECIP criteria: focus in volume

Jeremie Calais PSMA conference - UCSF/UCLA/PCF/Urotoday MIM Software UroToday.com Danny Mena - nuclear medicine Nuclear Medicine World

Comparing the SPLASH ECLIPSE and PSMAfore trials of Lutetium-177-PSMA therapy in the pre-chemotherapy mCRPC space at the #2024PSMAconference with Oliver Sartor, Mike Morris and Tom Hope

The PRIMARY score explained by its creator Louise Emmett at the #PSMAconference

The UC San Francisco UCLA Prostate Cancer Foundation #PSMAConference starts today! Learn from physicians, medical oncologists, radiation oncologists, urologists, APPs, and leaders in the field! #StayTuned for coverage from top talks on UroToday! Thomas Hope Jeremie Calais Zach Klaassen

The 2024 PSMA Conference has started, kicked off with Rob Flavell. Live on zoom for over 300 virtual attendees.

The UCSF-UCLA-PCF 2024 PSMA Conference is coming up (Jan 18/19th). The session comparing PSMAfore, SPLASH and ECLIPSE is even more relevant with the recent release of the SPLASH results. Register in person or virtually! psmaconference.ucsf.edu

Thomas Hope Thanks Thomas Hope I had fun presenting our work and it sparked thoughtful questions from the audience as well! Had a fantastic time at #RSNA2023 . Loved how it brought together different radiology sub specialities under one roof to deliver intriguing topics and shared insights.